SCHEMBL29030482

SCHEMBL29030482

CCOCOc1cc(C=O)ccc1-c1nnc(NC2CCCN(CC(=O)O)C2)c2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 6/20 0.40
EHMT2 Q96KQ7 2/20 0.35
BTK Q06187 1/20 0.35
JUN P05412 3/20 0.35
MAPK8 P45983 3/20 0.35
MAPK9 P45984 3/20 0.35
CDK2 P24941 2/20 0.35
MAPK10 P53779 2/20 0.35
PIK3CD O00329 2/20 0.35
KDM4E B2RXH2 2/20 0.34
GABRA5 P31644 2/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
EGFR P00533 1/20 0.33
JAK3 P52333 1/20 0.33
ITK Q08881 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29030480 1.00 NLRP3 (0.40) NLRP3EHMT2BTKJUNMAPK8
SCHEMBL25302366 0.94 PIK3CD (0.41) NLRP3EHMT2BTKJUNMAPK8
SCHEMBL25302362 0.94 PIK3CD (0.41) NLRP3EHMT2BTKJUNMAPK8
SCHEMBL25256084 0.91 NLRP3 (0.42) NLRP3EHMT2BTKPIK3CDKDM4E
SCHEMBL30488527 0.91 NLRP3 (0.42) NLRP3EHMT2BTKPIK3CDKDM4E
SCHEMBL25302706 0.91 NLRP3 (0.42) NLRP3EHMT2BTKPIK3CDKDM4E
SCHEMBL31197253 0.89 NLRP3 (0.39) NLRP3EHMT2BTKCDK2PIK3CD
SCHEMBL29030517 0.88 NLRP3 (0.40) NLRP3EHMT2BTKJUNMAPK8
SCHEMBL29030518 0.88 NLRP3 (0.40) NLRP3EHMT2BTKJUNMAPK8
SCHEMBL25296227 0.88 NLRP3 (0.50) NLRP3BTKCDK2ALDH1A1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116410140-A NLRP3 inflammation corpuscle inhibitor and application thereof 药捷安康(南京)科技股份有限公司 2023-07-11 CN disclosed